Science

Lung Cancer

Dec 24, 2024, 00:24

Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer

Ryan Nipp, Oncologist at University of Oklahoma, shared a recent article by Anne Gulbech Ording on X:

“Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study.”

Title: Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study

Authors: Anne Gulbech Ording, Flemming Skjøth, Laurids Østergaard Poulsen, Weronika Maria Szejniuk, Erik Jakobsen, Thomas Decker Christensen, Simon Noble and Thure Filskov Overvad

Lung Cancer

Ryan Nipp, M.D., MPH, gastrointestinal oncologist and cancer outcomes researcher at OU Health Stephenson Cancer Center. His research platform consists of studies interfacing between palliative care, geriatric oncology and health services research. He completed an internal medicine residency at Duke University and oncology fellowship at Dana-Farber/Harvard Cancer Center.

More posts featuring Ryan Nipp.

Anne Gulbech Ording anticancer therapy cancer Flemming Skjøth Laurids Østergaard Poulsen Lung cancer OncoDaily Oncology Ryan Nipp therapy Thure Filskov Overvad toxicity University of Oklahoma Weronika Maria Szejniuk

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Tedros Adhanom Ghebreyesus: The WHO Academy has opened its door to the world

Special Coverage